The EU Research & Innovation magazine
Today’s ‘headline’ article
A breakthrough in prosthetics technology by EU-funded researchers will provide amputees with clinically and commercially viable artificial limbs offering intuitive, proportional ...
Publications, documents & newsletters
Frontier research (ERC)
Information & Communication
Key Enabling Technologies
Marie Skłodowska-Curie Actions
Social science & humanities
Synergies with Structural funds
(including the Seal of Excellence)
Acetylsalicylic acid, most commonly known as aspirin, was already part of the Egyptian pharmacopeia, used also in ancient Greece and in the Middle Ages to break fevers. Taken all over the world to kill pain and reduce inflammation, today aspirin helps to prevent heart attacks, strokes and blood clots. Its emerging role in preventing and treating cancer is on the rise too. But how does this drug act on your blood cells? ERC grantee Prof Valerie O'Donnell works on the answer.
Green Week 2016 Partner event: 'EU - Brazil actions for sustainable cities'
30 May 2016, Brussels
10th GEO European Projects Workshop 2016
31 May - 2 June 2016, Berlin